Skip to main content
. 2016 Jun 7;2016(6):CD005542. doi: 10.1002/14651858.CD005542.pub3

Summary of findings for the main comparison. CSII versus MDI: maternal outcomes.

Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of insulin for pregnant women with diabetes
Patient or population: pregnant women with diabetes
 Setting: 3 studies in Italy
 Intervention: CSII
 Comparison: MDI
Outcomes Anticipated absolute effects* (95% CI) Relative effect
 (95% CI) № of participants
 (studies) Quality of the evidence
 (GRADE) Comments
Risk with MDI Risk with GRADE CSII
Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia)     (0 studies) outcome not reported  
Caesarean section Study population RR 1.09
 (0.66 to 1.77) 71
 (3 RCTs) ⊕⊝⊝⊝
 VERY LOW 1 2  
444 per 1000 484 per 1000
 (293 to 787)
Moderate
438 per 1000 477 per 1000
 (289 to 774)
Development of Type 2 diabetes     (0 studies) outcome not reported  
Perineal trauma     (0 studies) outcome not reported  
Return to pre‐pregnancy weight     (0 studies) outcome not reported  
Postnatal depression     (0 studies) outcome not reported  
Induction of labour     (0 studies) outcome not reported  
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 
 CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidenceHigh quality: We are very confident that the true effect lies close to that of the estimate of the effect
 Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
 Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
 Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 All studies contributing data had design limitations.

2 Wide confidence interval crossing the line of no effect, and small sample size.